Shanghai Shen Lian Biomedical Corporation
SSE:688098.SS
5.99 (CNY) • At close June 9, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 303.415 | 301.487 | 328.595 | 358.429 | 337.732 | 253.809 | 275.137 | 302.076 | 267.705 | 240.923 | 203.653 | 193.094 |
| Kosten van de omzet
| 120.612 | 87.934 | 81.396 | 86.987 | 55.095 | 44.953 | 54.568 | 60.506 | 58.383 | 51.285 | 44.49 | 42.28 |
| Brutowinst
| 182.803 | 213.553 | 247.199 | 271.442 | 282.638 | 208.856 | 220.57 | 241.57 | 209.323 | 189.638 | 159.163 | 150.813 |
| Brutowinstmarge
| 0.602 | 0.708 | 0.752 | 0.757 | 0.837 | 0.823 | 0.802 | 0.8 | 0.782 | 0.787 | 0.782 | 0.781 |
| Onderzoek- en ontwikkelingskosten
| 0 | 44.527 | 39.039 | 34.947 | 31.911 | 26.564 | 21.287 | 16.649 | 16.746 | 12.658 | 11.924 | 10.913 |
| Algemene en administratieve kosten
| 0 | 25.545 | 27.703 | 27.857 | 18.84 | 21.249 | 17.065 | 43.075 | 40.424 | 46.998 | 49.233 | 59.569 |
| Verkoop- en marketingkosten
| 0 | 84.386 | 73.116 | 63.373 | 63.994 | 58.927 | 63.425 | 73.477 | 62.914 | 56.203 | 45.06 | 43.457 |
| Verkoop-, algemene en administratieve kosten
| 96.36 | 109.931 | 100.82 | 91.23 | 82.834 | 80.176 | 80.49 | 116.553 | 103.338 | 103.201 | 94.294 | 103.025 |
| Overige kosten
| 93.599 | 22.976 | 28.005 | 28.781 | 38.537 | 20.302 | 0.372 | 1.942 | 2.524 | -1.682 | 4.285 | 1.288 |
| Bedrijfskosten
| 239.314 | 177.434 | 167.864 | 154.958 | 153.283 | 127.042 | 125.249 | 128.178 | 121.856 | 104.133 | 95.131 | 104.3 |
| Bedrijfsresultaat
| -57.194 | 36.119 | 75.235 | 128.686 | 147.394 | 90.856 | 100.943 | 114.237 | 88.441 | 88.685 | 72.17 | 49.752 |
| Bedrijfsresultaat ratio
| -0.188 | 0.12 | 0.229 | 0.359 | 0.436 | 0.358 | 0.367 | 0.378 | 0.33 | 0.368 | 0.354 | 0.258 |
| Totaal overige inkomsten en kosten netto
| -0.248 | 0.146 | -0.684 | -2.706 | 2.599 | -0.019 | 0.372 | 1.942 | 2.524 | -1.682 | 4.285 | 1.288 |
| Inkomen voor belasting
| -57.441 | 36.265 | 74.551 | 125.98 | 149.993 | 90.837 | 101.316 | 116.179 | 90.965 | 87.003 | 76.455 | 51.041 |
| Inkomen voor belasting ratio
| -0.189 | 0.12 | 0.227 | 0.351 | 0.444 | 0.358 | 0.368 | 0.385 | 0.34 | 0.361 | 0.375 | 0.264 |
| Belastingkosten
| -8.693 | 6.415 | 13.58 | 21.521 | 20.625 | 12.88 | 13.736 | 17.501 | 17.493 | 11.159 | 15.315 | 9.217 |
| Nettowinst
| -45.536 | 31.519 | 61.101 | 110.202 | 129.514 | 77.957 | 87.58 | 98.678 | 73.472 | 75.844 | 61.14 | 41.823 |
| Nettowinstmarge
| -0.15 | 0.105 | 0.186 | 0.307 | 0.383 | 0.307 | 0.318 | 0.327 | 0.274 | 0.315 | 0.3 | 0.217 |
| WPA (Winst Per Aandeel)
| -0.11 | 0.08 | 0.15 | 0.27 | 0.32 | 0.19 | 0.26 | 0.3 | 0.23 | 0.88 | 0.71 | 0.49 |
| Verwaterde WPA
| -0.11 | 0.08 | 0.15 | 0.27 | 0.31 | 0.19 | 0.26 | 0.3 | 0.23 | 0.88 | 0.71 | 0.49 |
| EBITDA
| 11.86 | 99.743 | 136.404 | 169.742 | 170.841 | 105.817 | 113.246 | 124.975 | 100.973 | 93.623 | 72.357 | 54.339 |
| EBITDA ratio
| 0.039 | 0.331 | 0.415 | 0.474 | 0.506 | 0.417 | 0.412 | 0.414 | 0.377 | 0.389 | 0.355 | 0.281 |